Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Ro-44-3888> ?p ?o. }
Showing items 1 to 29 of
29
with 100 items per page.
- Ro-44-3888 abstract "Ro 44-3888 is a non-peptidic, selective and reversible glycoprotein IIb/IIIa inhibitor. It is the active metabolite of sibrafiban. It was being investigated as a treatment for heart conditions, including myocardial infarctions. The development of Ro 44-3888 and sibrafiban was discontinued in 1999 following unfavorable Phase III efficacy data.".
- Ro-44-3888 thumbnail Ro_44-3888.svg?width=300.
- Ro-44-3888 wikiPageID "31742492".
- Ro-44-3888 wikiPageRevisionID "574364250".
- Ro-44-3888 c "18".
- Ro-44-3888 chembl "65267".
- Ro-44-3888 h "24".
- Ro-44-3888 hasPhotoCollection Ro-44-3888.
- Ro-44-3888 molecularWeight "376.4".
- Ro-44-3888 n "4".
- Ro-44-3888 o "5".
- Ro-44-3888 smiles "C[C@H]CN2CCCOCCO".
- Ro-44-3888 stdinchi "InChI=1S/C18H24N4O5/c1-111822-8-6-1427-10-1524/h2-5,11,14H,6-10H2,1H3,/t11-/m0/s1".
- Ro-44-3888 stdinchikey "BHOGTSLQMNCJHA-NSHDSACASA-N".
- Ro-44-3888 width "300".
- Ro-44-3888 subject Category:Amidines.
- Ro-44-3888 subject Category:Benzamides.
- Ro-44-3888 subject IIIa_inhibitors.
- Ro-44-3888 subject Category:Piperidines.
- Ro-44-3888 type Drug.
- Ro-44-3888 type FunctionalSubstance.
- Ro-44-3888 comment "Ro 44-3888 is a non-peptidic, selective and reversible glycoprotein IIb/IIIa inhibitor. It is the active metabolite of sibrafiban. It was being investigated as a treatment for heart conditions, including myocardial infarctions. The development of Ro 44-3888 and sibrafiban was discontinued in 1999 following unfavorable Phase III efficacy data.".
- Ro-44-3888 label "Ro-44-3888".
- Ro-44-3888 sameAs m.0gts__p.
- Ro-44-3888 sameAs Q7339192.
- Ro-44-3888 sameAs Q7339192.
- Ro-44-3888 wasDerivedFrom Ro-44-3888?oldid=574364250.
- Ro-44-3888 depiction Ro_44-3888.svg.
- Ro-44-3888 isPrimaryTopicOf Ro-44-3888.